Search Results - "Balfour, H"

Refine Results
  1. 1

    Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections by ODUMADE, Oludare A, HOGQUIST, Kristin A, BALFOUR, Henry H

    Published in Clinical Microbiology Reviews (01-01-2011)
    “…Classifications Services CMR Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    Primary Epstein-Barr virus infection with and without infectious mononucleosis by Rostgaard, Klaus, Balfour, Jr, Henry H, Jarrett, Ruth, Erikstrup, Christian, Pedersen, Ole, Ullum, Henrik, Nielsen, Lars Peter, Voldstedlund, Marianne, Hjalgrim, Henrik

    Published in PloS one (17-12-2019)
    “…Infectious mononucleosis (IM) is a common adverse presentation of primary infection with Epstein-Barr virus (EBV) in adolescence and later, but is rarely…”
    Get full text
    Journal Article
  3. 3

    The promise of a prophylactic Epstein–Barr virus vaccine by Balfour , Henry H., Schmeling, David O., Grimm-Geris, Jennifer M.

    Published in Pediatric research (01-01-2020)
    “…The worldwide burden of disease due to Epstein–Barr virus (EBV) infection is enormous. Diseases include endemic Burkitt lymphoma, infectious mononucleosis,…”
    Get full text
    Journal Article
  4. 4

    The Incubation Period of Primary Epstein-Barr Virus Infection: Viral Dynamics and Immunologic Events by Dunmire, Samantha K, Grimm, Jennifer M, Schmeling, David O, Balfour, Jr, Henry H, Hogquist, Kristin A

    Published in PLoS pathogens (01-12-2015)
    “…Epstein-Barr virus (EBV) is a human herpesvirus that causes acute infectious mononucleosis and is associated with cancer and autoimmune disease. While many…”
    Get full text
    Journal Article
  5. 5

    Age-Specific Prevalence of Epstein-Barr Virus Infection Among Individuals Aged 6-19 Years in the United States and Factors Affecting Its Acquisition by Balfour, Henry H., Sifakis, Frangiscos, Sliman, Joseph A., Knight, Jennifer A., Schmeling, David O., Thomas, William

    Published in The Journal of infectious diseases (15-10-2013)
    “…Background. Data on the age-specific prevalence of Epstein-Barr virus (EBV) infection are relevant for determining when to administer a prophylactic vaccine…”
    Get full text
    Journal Article
  6. 6

    Antivirals for COPD? by Balfour, Henry H.

    Published in Chest (01-09-2023)
    Get full text
    Journal Article
  7. 7

    Primary Epstein-Barr virus infection by Dunmire, Samantha K., Verghese, Priya S., Balfour, Henry H.

    Published in Journal of clinical virology (01-05-2018)
    “…•Age-specific prevalence of EBV infection may be declining in developed countries.•Close personal contact and fomites implicated but not proven to transmit…”
    Get full text
    Journal Article
  8. 8

    Age-Specific Prevalence of Epstein-Barr Virus Infection Among Minnesota Children: Effects of Race/Ethnicity and Family Environment by Condon, Lawrence M., Cederberg, Laurel E., Rabinovitch, Mark D., Liebo, Rhoda V., Go, Janice C., Delaney, Amanda S., Schmeling, David O., Thomas, William, Balfour, Henry H.

    Published in Clinical infectious diseases (15-08-2014)
    “…Background. Primary Epstein-Barr virus (EBV) infection affects the host differently according to when in life it is acquired. Understanding risk factors for…”
    Get full text
    Journal Article
  9. 9

    Multicenter Comparison of Different Real-Time PCR Assays for Quantitative Detection of Epstein-Barr Virus by Hayden, R.T, Hokanson, K.M, Pounds, S.B, Bankowski, M.J, Belzer, S.W, Carr, J, Diorio, D, Forman, M.S, Joshi, Y, Hillyard, D, Hodinka, R.L, Nikiforova, M.N, Romain, C.A, Stevenson, J, Valsamakis, A, Balfour, H.H. Jr

    Published in Journal of Clinical Microbiology (01-01-2008)
    “…Quantification of Epstein-Barr virus (EBV) in peripheral blood is important for the diagnosis and management of serious EBV diseases, including posttransplant…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Infectious mononucleosis by Balfour, Henry H, Dunmire, Samantha K, Hogquist, Kristin A

    Published in Clinical & translational immunology (01-02-2015)
    “…Infectious mononucleosis is a clinical entity characterized by pharyngitis, cervical lymph node enlargement, fatigue and fever, which results most often from a…”
    Get full text
    Journal Article
  12. 12

    Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients by Verghese, Priya S., Evans, Michael D., Hanson, Amy, Hathi, Justina, Chinnakotla, Srinath, Matas, Arthur, Balfour, Henry H.

    Published in Journal of clinical virology (01-06-2024)
    “…•Valacyclovir is an effective anti-viral prophylaxis for CMV after adult and pediatric kidney transplant.•Valacyclovir is better tolerated with less…”
    Get full text
    Journal Article
  13. 13

    Likes, comments, action! An examination of the Facebook audience engagement strategies used by strategic impact documentary by Balfour, Virginia H

    “…In the digital age, a new breed of strategic communications campaign has emerged which blurs boundaries between factual media, entertainment, marketing and…”
    Get full text
    Journal Article
  14. 14

    EBV-positive Mucocutaneous Ulcer in Organ Transplant Recipients: A Localized Indolent Posttransplant Lymphoproliferative Disorder by Hart, Melissa, Thakral, Beenu, Yohe, Sophia, Balfour, Henry H, Singh, Charanjeet, Spears, Michael, McKenna, Robert W

    Published in The American journal of surgical pathology (01-11-2014)
    “…Epstein-Barr virus (EBV)-positive mucocutaneous ulcer (EBV MCU) is a B-cell lymphoproliferative disorder occurring in elderly or iatrogenic immunocompromised…”
    Get full text
    Journal Article
  15. 15

    Progress, prospects, and problems in Epstein-Barr virus vaccine development by Balfour, Henry H

    Published in Current opinion in virology (01-06-2014)
    “…•Prophylactic and therapeutic EBV vaccines have been tested but none is licensed.•Best progress to date: prevention of infectious mononucleosis by a gp350…”
    Get full text
    Journal Article
  16. 16

    Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus by Hendricks, Deborah W, Balfour, Jr, Henry H, Dunmire, Samantha K, Schmeling, David O, Hogquist, Kristin A, Lanier, Lewis L

    Published in The Journal of immunology (1950) (15-05-2014)
    “…CMV induces the expansion of a unique subset of human NK cells expressing high levels of the activating CD94-NKG2C receptor that persist after control of the…”
    Get full text
    Journal Article
  17. 17

    Primary EBV infection induces an expression profile distinct from other viruses but similar to hemophagocytic syndromes by Dunmire, Samantha K, Odumade, Oludare A, Porter, Jean L, Reyes-Genere, Juan, Schmeling, David O, Bilgic, Hatice, Fan, Danhua, Baechler, Emily C, Balfour, Jr, Henry H, Hogquist, Kristin A

    Published in PloS one (17-01-2014)
    “…Epstein-Barr Virus (EBV) causes infectious mononucleosis and establishes lifelong infection associated with cancer and autoimmune disease. To better understand…”
    Get full text
    Journal Article
  18. 18

    Screening for Epstein-Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method by Grimm-Geris, J M, Dunmire, S K, Duval, L M, Filtz, E A, Leuschen, H J, Schmeling, D O, Kulasingam, S L, Balfour, H H

    Published in Epidemiology and infection (01-01-2019)
    “…Prophylactic vaccines against Epstein-Barr virus (EBV) are under development. EBV-naïve college freshmen are ideal candidates for an efficacy trial, because…”
    Get full text
    Journal Article
  19. 19
  20. 20